ECS Botanics Holdings Ltd. provided revenue guidance for the quarter ended December 31, 2021. For the quarter, the company expects to record revenue of approximately $1.5 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | 0.00% | -5.26% | -20.00% |
17/05 | ECS Botanics Secures First B2C Medicinal Cannabis Contract | MT |
27/02 | ECS Botanics Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 1.54Cr | |
-.--% | 34Cr | |
+18.11% | 23Cr | |
+3.09% | 21Cr | |
+38.37% | 18Cr | |
+145.74% | 14Cr | |
-28.57% | 12Cr | |
+29.80% | 12Cr | |
-46.53% | 11Cr | |
+7.69% | 9.35Cr |
- Stock Market
- Equities
- ECS Stock
- News ECS Botanics Holdings Ltd
- ECS Botanics Holdings Ltd. Provides Revenue Guidance for the Quarter Ended December 31, 2021